View in EDS HTML Full Text PDF Full Text

Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone.

Saved in:
Bibliographic Details
Title: Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone.
Authors: Skinner-Adams TS; 1Griffith Institute for Drug Discovery, Griffith University, Nathan, QLD 4111 Australia., Fisher GM; 1Griffith Institute for Drug Discovery, Griffith University, Nathan, QLD 4111 Australia., Riches AG; 2Commonwealth Scientific and Industrial Research Organization, Biomedical Manufacturing, Clayton, VIC 3168 Australia., Hutt OE; 2Commonwealth Scientific and Industrial Research Organization, Biomedical Manufacturing, Clayton, VIC 3168 Australia., Jarvis KE; 2Commonwealth Scientific and Industrial Research Organization, Biomedical Manufacturing, Clayton, VIC 3168 Australia., Wilson T; 2Commonwealth Scientific and Industrial Research Organization, Biomedical Manufacturing, Clayton, VIC 3168 Australia., von Itzstein M; 3Institute for Glycomics, Griffith University Gold Coast Campus, Gold Coast, QLD 4222 Australia., Chopra P; 3Institute for Glycomics, Griffith University Gold Coast Campus, Gold Coast, QLD 4222 Australia., Antonova-Koch Y; School of Medicine, University of California, San Diego, La Jolla, CA 92093 USA.; 7Present Address: California Institute for Biomedical Research (Calibr), La Jolla, CA 92037 USA., Meister S; School of Medicine, University of California, San Diego, La Jolla, CA 92093 USA.; Present Address: Beckman Coulter Life Sciences in Indianapolis, Indianapolis, IN 46268 USA., Winzeler EA; School of Medicine, University of California, San Diego, La Jolla, CA 92093 USA., Clarke M; 1Griffith Institute for Drug Discovery, Griffith University, Nathan, QLD 4111 Australia., Fidock DA; 5Department of Microbiology and Immunology, and Division of Infectious Diseases, Department of Medicine, Columbia University Medical Center, New York, NY 10032 USA., Burrows JN; 6Medicines for Malaria Venture (MMV), Route de Pré Bois 20, Geneva, 1215 Switzerland., Ryan JH; 2Commonwealth Scientific and Industrial Research Organization, Biomedical Manufacturing, Clayton, VIC 3168 Australia., Andrews KT; 1Griffith Institute for Drug Discovery, Griffith University, Nathan, QLD 4111 Australia.
Source: Communications biology [Commun Biol] 2019 May 03; Vol. 2, pp. 166. Date of Electronic Publication: 2019 May 03 (Print Publication: 2019).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: eCollection Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31069275
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Skinner-Adams+TS%22">Skinner-Adams TS</searchLink>; 1Griffith Institute for Drug Discovery, Griffith University, Nathan, QLD 4111 Australia.<br /><searchLink fieldCode="AU" term="%22Fisher+GM%22">Fisher GM</searchLink>; 1Griffith Institute for Drug Discovery, Griffith University, Nathan, QLD 4111 Australia.<br /><searchLink fieldCode="AU" term="%22Riches+AG%22">Riches AG</searchLink>; 2Commonwealth Scientific and Industrial Research Organization, Biomedical Manufacturing, Clayton, VIC 3168 Australia.<br /><searchLink fieldCode="AU" term="%22Hutt+OE%22">Hutt OE</searchLink>; 2Commonwealth Scientific and Industrial Research Organization, Biomedical Manufacturing, Clayton, VIC 3168 Australia.<br /><searchLink fieldCode="AU" term="%22Jarvis+KE%22">Jarvis KE</searchLink>; 2Commonwealth Scientific and Industrial Research Organization, Biomedical Manufacturing, Clayton, VIC 3168 Australia.<br /><searchLink fieldCode="AU" term="%22Wilson+T%22">Wilson T</searchLink>; 2Commonwealth Scientific and Industrial Research Organization, Biomedical Manufacturing, Clayton, VIC 3168 Australia.<br /><searchLink fieldCode="AU" term="%22von+Itzstein+M%22">von Itzstein M</searchLink>; 3Institute for Glycomics, Griffith University Gold Coast Campus, Gold Coast, QLD 4222 Australia.<br /><searchLink fieldCode="AU" term="%22Chopra+P%22">Chopra P</searchLink>; 3Institute for Glycomics, Griffith University Gold Coast Campus, Gold Coast, QLD 4222 Australia.<br /><searchLink fieldCode="AU" term="%22Antonova-Koch+Y%22">Antonova-Koch Y</searchLink>; School of Medicine, University of California, San Diego, La Jolla, CA 92093 USA.; 7Present Address: California Institute for Biomedical Research (Calibr), La Jolla, CA 92037 USA.<br /><searchLink fieldCode="AU" term="%22Meister+S%22">Meister S</searchLink>; School of Medicine, University of California, San Diego, La Jolla, CA 92093 USA.; Present Address: Beckman Coulter Life Sciences in Indianapolis, Indianapolis, IN 46268 USA.<br /><searchLink fieldCode="AU" term="%22Winzeler+EA%22">Winzeler EA</searchLink>; School of Medicine, University of California, San Diego, La Jolla, CA 92093 USA.<br /><searchLink fieldCode="AU" term="%22Clarke+M%22">Clarke M</searchLink>; 1Griffith Institute for Drug Discovery, Griffith University, Nathan, QLD 4111 Australia.<br /><searchLink fieldCode="AU" term="%22Fidock+DA%22">Fidock DA</searchLink>; 5Department of Microbiology and Immunology, and Division of Infectious Diseases, Department of Medicine, Columbia University Medical Center, New York, NY 10032 USA.<br /><searchLink fieldCode="AU" term="%22Burrows+JN%22">Burrows JN</searchLink>; 6Medicines for Malaria Venture (MMV), Route de Pré Bois 20, Geneva, 1215 Switzerland.<br /><searchLink fieldCode="AU" term="%22Ryan+JH%22">Ryan JH</searchLink>; 2Commonwealth Scientific and Industrial Research Organization, Biomedical Manufacturing, Clayton, VIC 3168 Australia.<br /><searchLink fieldCode="AU" term="%22Andrews+KT%22">Andrews KT</searchLink>; 1Griffith Institute for Drug Discovery, Griffith University, Nathan, QLD 4111 Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101719179%22">Communications biology</searchLink> [Commun Biol] 2019 May 03; Vol. 2, pp. 166. <i>Date of Electronic Publication: </i>2019 May 03 (<i>Print Publication: </i>2019).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+UK%22">Nature Publishing Group UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101719179 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2399-3642 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223993642%22">23993642 </searchLink><i>NLM ISO Abbreviation: </i>Commun Biol
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31069275
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s42003-019-0397-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 166
    Titles:
      – TitleFull: Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Skinner-Adams TS
      – PersonEntity:
          Name:
            NameFull: Fisher GM
      – PersonEntity:
          Name:
            NameFull: Riches AG
      – PersonEntity:
          Name:
            NameFull: Hutt OE
      – PersonEntity:
          Name:
            NameFull: Jarvis KE
      – PersonEntity:
          Name:
            NameFull: Wilson T
      – PersonEntity:
          Name:
            NameFull: von Itzstein M
      – PersonEntity:
          Name:
            NameFull: Chopra P
      – PersonEntity:
          Name:
            NameFull: Antonova-Koch Y
      – PersonEntity:
          Name:
            NameFull: Meister S
      – PersonEntity:
          Name:
            NameFull: Winzeler EA
      – PersonEntity:
          Name:
            NameFull: Clarke M
      – PersonEntity:
          Name:
            NameFull: Fidock DA
      – PersonEntity:
          Name:
            NameFull: Burrows JN
      – PersonEntity:
          Name:
            NameFull: Ryan JH
      – PersonEntity:
          Name:
            NameFull: Andrews KT
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 05
              Text: 2019 May 03
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 2399-3642
          Numbering:
            – Type: volume
              Value: 2
          Titles:
            – TitleFull: Communications biology
              Type: main
ResultId 1